| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Darunavir Impurity A |
地瑞那韋雜質(zhì)A |
169280-56-2 |
詳細(xì)
|
| Desoximetasone Impurity E |
醋酸地塞米松EP雜質(zhì)E |
1524-94-3 |
詳細(xì)
|
| Conivaptan impurity F |
考尼伐坦雜質(zhì)F |
|
詳細(xì)
|
| Erlotinib Hydrochloride iMpurity 15 |
厄洛替尼雜質(zhì)15 |
|
詳細(xì)
|
| Dexamethasone EP Impurity F |
地塞米松EP雜質(zhì)F |
382-67-2 |
詳細(xì)
|
| Erlotinib Impurity 1 |
厄洛替尼雜質(zhì)1 |
2204518-92-1 |
詳細(xì)
|
| Creatine Phosphate Sodium Impurity 9;2-(3-(bis(benzyloxy)phosphoryl)-1-methylguanidino)acetic acid |
磷酸肌酸鈉雜質(zhì)9 |
|
詳細(xì)
|
| Darunavir Impurity 19 |
地瑞那韋雜質(zhì) |
1402142-62-4 |
詳細(xì)
|
| Captopril Related Compound 6 |
卡托普利相關(guān)化合物6 |
69570-39-4 |
詳細(xì)
|
| Clozapine EP Impurity C-d8 (N-Desmethyl Clozapine-d8) |
氯氮平-d4 |
204395-52-8 |
詳細(xì)
|
| Cleviprex Impurity 8 |
丁酸氯維地平雜質(zhì)8 |
|
詳細(xì)
|
| Desmethyl Erlotinib Carboxylate Acid |
厄洛替尼雜質(zhì) |
1170354-84-3 |
詳細(xì)
|
| DNV-II impurity 1 |
DNV-II雜質(zhì)1 |
1005324-46-8 |
詳細(xì)
|
| Captopril Impurity 1 |
卡托普利雜質(zhì)1 |
119238-52-7 |
詳細(xì)
|
| Rosuvastatin EP Impurity A |
地屈孕酮雜質(zhì) |
25093-47-4 |
詳細(xì)
|
| Creatine Phosphate Sodium Impurity 10;2-(3-((benzyloxy)(hydroxy)phosphoryl)-1-methylguanidino)acetic acid |
磷酸肌酸鈉雜質(zhì)10 |
|
詳細(xì)
|
| Darunavir Impurity 12 |
達(dá)魯那韋雜質(zhì)11 |
866594-60-7 |
詳細(xì)
|
| (R)-Amlodipine |
醋酸地塞米松EP雜質(zhì)F |
2884-51-7 |
詳細(xì)
|
| Darunavir-N-Glucuronide |
達(dá)魯那韋雜質(zhì) |
1159613-25-8 |
詳細(xì)
|
| Erlotinib Impurity |
厄洛替尼O-去甲基代謝物異構(gòu)體(M14)HCl |
183320-51-6 |
詳細(xì)
|
| Erlotinib Impurity 1 |
厄洛替尼雜質(zhì) |
882420-22-6 |
詳細(xì)
|
| Pitavastatin Impurity 54 |
匹伐他汀雜質(zhì)54 |
1258947-30-6 |
詳細(xì)
|
| 4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl) |
泊沙康唑?qū)τ钞悩?gòu)體 |
|
詳細(xì)
|
| Dexamethasone EP Impurity D |
地塞米松EP雜質(zhì)D |
24916-90-3 |
詳細(xì)
|
| Darunavir Impurity 2 |
地瑞那韋雜質(zhì)2 |
1526916-57-3 |
詳細(xì)
|
| Darunavir Impurity 15 |
達(dá)魯那韋雜質(zhì)14 |
1418639-27-6 |
詳細(xì)
|
| Desoximetasone Impurity C |
醋酸地塞米松EP雜質(zhì)C |
|
詳細(xì)
|
| Darunavir Ethanolate |
地瑞那韋雜質(zhì) |
635728-49-3 |
詳細(xì)
|
| Captopril-d3 |
卡托普利雜質(zhì) |
1356383-38-4 |
詳細(xì)
|
| Captopril Related Compound 10 |
卡托普利相關(guān)化合物10 |
78636-31-4 |
詳細(xì)
|
| Cinacalcet impurity 20;N-(1-(7,8-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide hydrochloride |
西那卡塞雜質(zhì)20 |
|
詳細(xì)
|
| Creatine Phosphate Sodium Impurity 3;2-(3-cyano-1-methylguanidino)acetic acid |
磷酸肌酸鈉雜質(zhì)3 |
|
詳細(xì)
|
| Erlotinib Impurity 11 |
厄洛替尼雜質(zhì)11 |
950596-59-5 |
詳細(xì)
|
| Darunavir Impurity 10 |
達(dá)魯那韋雜質(zhì)9 |
1932330-83-0 |
詳細(xì)
|
| Darunavir Impurity 7 (S,S-Isomer) |
達(dá)魯那韋雜質(zhì)7(S,S-異構(gòu)體) |
192800-79-6 |
詳細(xì)
|
| Desoximetasone Impurity 16 |
地塞米松EP雜質(zhì)16 |
2265-64-7 |
詳細(xì)
|
| Desoximetasone Impurity 17 |
地塞米松甲磺酸鈉 |
3936-02-5 |
詳細(xì)
|
| DL-Folic Acid |
葉酸雜質(zhì)1 |
65165-92-6 |
詳細(xì)
|
| Captopril Related Compound 9 |
卡托普利相關(guān)化合物9 |
75479-46-8 |
詳細(xì)
|
| Captopril Impurity 1 |
卡托普利雜質(zhì)1 |
613256-52-3 |
詳細(xì)
|
| Clozapine-5-N-Glucuronide Sodium Salt |
氯氮平-5- N-葡糖苷酸鈉鹽 |
390651-03-3 |
詳細(xì)
|
| DNV-II impurity 2 |
DNV-II雜質(zhì)2 |
1133153-38-4 |
詳細(xì)
|
| Cinacalcet Impurity 7 |
西那卡塞雜質(zhì)7 |
1428118-39-1 |
詳細(xì)
|
| Cinacalcet impurity 18;(E)-N-(1-(5,6-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)acrylamide hydrochloride |
西那卡塞雜質(zhì)18 |
802918-35-0 |
詳細(xì)
|
| Clopidogrel Bisulfate Impurity 33 |
氯吡格雷雜質(zhì)13 |
2173294-69-2 |
詳細(xì)
|
| Dexamethasone-17-Ketone |
地塞米松17-酮 |
2285-53-2 |
詳細(xì)
|
| Creatine Phosphate Sodium Impurity 13;dibenzyl (1-methyl-4-oxoimidazolidin-2-ylidene)phosphoramidate |
磷酸肌酸鈉雜質(zhì)13 |
|
詳細(xì)
|
| Clozapine EP Impurity C-d8 (N-Desmethyl Clozapine-d8) |
氯氮平-d8 |
1185053-50-2 |
詳細(xì)
|
| Dilinavir |
地瑞那韋雜質(zhì) |
206361-99-1 |
詳細(xì)
|
| D-Folic Acid |
葉酸雜質(zhì) |
65165-91-5 |
詳細(xì)
|
| Desoximetasone Impurity |
地塞米松生物素 |
85679-56-7 |
詳細(xì)
|
| Darunavir-O-Glucuronide |
達(dá)魯那韋雜質(zhì) |
1159613-27-0 |
詳細(xì)
|
| Darunavir Impurity 9 |
達(dá)魯那韋雜質(zhì)8(R,R-異構(gòu)體) |
866594-61-8 |
詳細(xì)
|
| Dabigatran Etexilate iMpurity K |
達(dá)比加群酯雜質(zhì)K |
|
詳細(xì)
|
| Dabigatran Etexilate iMpurity P |
達(dá)比加群酯雜質(zhì)P |
|
詳細(xì)
|
| Clopidogrel Impurity 1;5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)thieno[3,2-c]pyridin-5-ium chloride |
氯吡格雷雜質(zhì)1 |
|
詳細(xì)
|
| Cilnidipine Impurity 27 |
地屈孕酮 |
152-62-5 |
詳細(xì)
|
| Clevidipine Butyrate Impurity 9;3-((butyryloxy)methyl) 5-methyl 4-(3,4-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
丁酸氯維地平雜質(zhì)9 |
|
詳細(xì)
|
|
氯吡格雷雜質(zhì)12 |
|
詳細(xì)
|
| Glycine impurity 10 |
氯吡格雷雜質(zhì)10 |
43189-20-4 |
詳細(xì)
|
| Cefoperazone impurity 30. |
頭孢哌酮鈉 |
62893-20-3 |
詳細(xì)
|
| Clozapine EP Impurity A |
氯氮平EP雜質(zhì)A |
50892-62-1 |
詳細(xì)
|
|
氯吡格雷雜質(zhì)11 |
|
詳細(xì)
|
| D-Fudosteine |
福多司坦 |
1023971-10-9 |
詳細(xì)
|
| Didesmethyl Erlotinib |
厄洛替尼雜質(zhì) |
183321-84-8 |
詳細(xì)
|
| Darunavir-d9 |
地瑞那韋雜質(zhì) |
1133378-37-6 |
詳細(xì)
|
| Captopril |
卡托普利雜質(zhì) |
62571-86-2 |
詳細(xì)
|
| Captopril EP Impurity N |
卡托普利雜質(zhì)4 |
65134-74-9 |
詳細(xì)
|
| Darunavir Impurity 14 |
達(dá)魯那韋雜質(zhì)13 |
143224-62-8 |
詳細(xì)
|
| Cinacalcet impurity 21;N-(1-(5,6-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide hydrochloride |
西那卡塞雜質(zhì)21 |
|
詳細(xì)
|
| Darunavir Impurity 11 |
達(dá)魯那韋雜質(zhì)10 |
1932353-11-1 |
詳細(xì)
|
| D-Darunavir |
地瑞那韋雜質(zhì) |
1399859-60-9 |
詳細(xì)
|
| Clopidogrel Impurity 49 |
氯吡格雷雜質(zhì)49 |
5402-55-1 |
詳細(xì)
|
| Captopril Related Compound 7 |
卡托普利雜質(zhì)10 |
65167-28-4 |
詳細(xì)
|
| Tacrolimus Diene |
去甲基他克莫司 |
132172-14-6 |
詳細(xì)
|
| Creatine Phosphate Sodium Impurity 1; sodium N-methylcarbamimidoylphosphoramidate |
磷酸肌酸鈉雜質(zhì)1 |
|
詳細(xì)
|
| Clopidogrel Impurity 2;5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-6,7-dihydrothieno[3,2-c]pyridin-5-ium bromide |
氯吡格雷雜質(zhì)2 |
|
詳細(xì)
|
| Erlotinib Hydrochloride iMpurity 14 |
厄洛替尼雜質(zhì)14 |
|
詳細(xì)
|
| Clozapine-d3 |
氯氮平-d3 |
1215691-72-7 |
詳細(xì)
|
| Dexamethasone Sodium Phosphate EP Impurity H |
地塞米松磷酸鈉EP雜質(zhì)H |
162968-22-1 |
詳細(xì)
|
| Creatine Phosphate Sodium Impurity 8;benzyl hydrogen (1-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)phosphoramidate |
磷酸肌酸鈉雜質(zhì)8 |
|
詳細(xì)
|
| Desoximetasone Impurity |
地塞米松17-甲酰氧基-17-酸 |
473273-04-0 |
詳細(xì)
|
| Clozapine EP Impurity C |
氯氮平EP雜質(zhì)C |
6104-71-8 |
詳細(xì)
|
| Tacrolimus EP Impurity E |
他克莫司雜質(zhì) |
104987-30-6 |
詳細(xì)
|
| Dabigatran Etexilate iMpurity Q |
達(dá)比加群酯雜質(zhì)Q |
|
詳細(xì)
|
| Erlotinib Impurity 68 |
厄洛替尼雜質(zhì)A |
183321-82-6 |
詳細(xì)
|
| Dexamethasone Impurity G |
地塞米松磷酸鈉EP雜質(zhì)G(地塞米松酸) |
1597-78-0 |
詳細(xì)
|
| Clopidogrel Metabolite 1;(E)-2-(1-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4-mercaptopiperidin-3-ylidene)acetic acid |
氯吡格雷代謝物1 |
|
詳細(xì)
|
| Glycine impurity 11 |
氯吡格雷雜質(zhì)9 |
532987-11-4 |
詳細(xì)
|
| (R)-N-(1-(naphthalen-2-yl)ethyl) |
西那卡塞雜質(zhì)10 |
|
詳細(xì)
|
| Noradrenaline Impurity 26 |
厄洛替尼 |
68304-21-3 |
詳細(xì)
|
| Cinacalcet impurity 22;(E)-N-(1-(5,6,7,8-tetrahydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)acrylamide hydrochloride |
西那卡塞雜質(zhì)22 |
|
詳細(xì)
|
| Erlotinib Hydrochloride iMpurity 18 |
厄洛替尼雜質(zhì)18 |
|
詳細(xì)
|
| Captopril Related Compound 5 |
卡托普利相關(guān)化合物5 |
74345-73-6 |
詳細(xì)
|
| Dapoxetine impurity 37 |
安非他酮雜質(zhì) |
936-59-4 |
詳細(xì)
|
| Captopril Impurity 2 |
卡托普利雜質(zhì)2 |
112243-88-6 |
詳細(xì)
|
| Darunavir Impurity 13 |
達(dá)魯那韋雜質(zhì)12 |
156636-67-8 |
詳細(xì)
|
| Desoximetasone Impurity B |
醋酸地塞米松EP雜質(zhì)B |
|
詳細(xì)
|
| Captopril EP Impurity J |
卡托普利EP雜質(zhì)J |
64838-55-7 |
詳細(xì)
|
| Desoximetasone Impurity |
6-羥基地塞米松(非對(duì)映異構(gòu)體混合物) |
82778-08-3 |
詳細(xì)
|